Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-7,973
Closed -$553K 994
2023
Q3
$553K Sell
7,973
-126
-2% -$9.52K 0.02% 664
2023
Q2
$656K Sell
8,099
-698
-8% -$57K 0.02% 627
2023
Q1
$710K Buy
8,797
+270
+3% +$21.7K 0.02% 656
2022
Q4
$638K Buy
+8,527
New +$607K 0.02% 665
2022
Q1
Sell
-3,254
Closed -$249K 1423
2021
Q4
$249K Buy
3,254
+530
+19% +$39K 0.01% 1174
2021
Q3
$201K Sell
2,724
-2,364
-46% -$177K 0.01% 1267
2021
Q2
$339K Buy
5,088
+2,170
+74% +$145K 0.01% 1019
2021
Q1
$217K Buy
+2,918
New +$222K 0.01% 1159

Other funds holding HOLX

Sigma Planning Corp's HOLX Position: Q4 2023 in Review

Sigma Planning Corp sold out of Hologic (HOLX) in Q4 2023, closing a stake of 7,973 shares — an estimated $553K sold.

Sigma Planning Corp first reported a position in HOLX in Q1 2021 and held it in 8 quarters. The position peaked at $710K in Q1 2023. 732 funds tracked by Wall St. Rank hold HOLX as of Q4 2023.

  • Sigma Planning Corp reported no remaining Hologic position as of Q4 2023 after selling out during the quarter.
  • Sigma Planning Corp sold 7,973 Hologic shares in Q4 2023, an estimated $553K.
  • Sigma Planning Corp first reported a position in Hologic in Q1 2021 and held it in 8 quarters.
  • Sigma Planning Corp's Hologic position peaked at $710K in Q1 2023.
  • 732 funds tracked by Wall St. Rank held Hologic as of Q4 2023.

Based on Sigma Planning Corp's 13F filing for Q4 2023, filed 1 Feb 2024.